BioSpace News Archive

Rocket Pharmaceuticals, Inc. announces that Gaurav Shah, M.D., Chief Executive Officer and President of Rocket is scheduled to present on Wednesday, May 15, 2019, at 3:40p.m.

Chesapeake Regional Medical Center installs CorPath® GRX Vascular Robotic Systems in all catheterization labs

Charles River Laboratories International, Inc. reported its results for the first quarter of 2019.

Also presented were results from a meta-analysis of DecisionDx-Melanoma in 1,479 patients which provides the highest level of evidence (1A) as an independent, significant predictor of risk in cutaneous melanoma

Repair Biotechnologies, Inc. announced $2.15 million in seed venture funding, to accelerate the preclinical development of its pipeline of drugs targeting thymus regeneration, cancer, and atherosclerosis.

Open-label, long-term extension data show durability of zilucoplan treatment effect, with sustained improvements observed in primary and secondary endpoints at 24 weeks

Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, reported financial results for the first quarter 2019.

Pfizer Inc. announced that the European Commission granted conditional marketing authorization for LORVIQUA®, as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer whose disease has progressed after alectinib or ceritinib as the first ALK tyrosine kinase inhibitor therapy, or crizotinib and at least one other ALK TKI.

Mr. Müsing, serving on ZyVersa’s Board of Directors for over 2 years, has been instrumental in evolution of the company, and diversification into the large and growing anti-inflammatory market with our novel inflammasome inhibitor targeting ASC

Regarded as the original teeth-whitening toothpaste brand, REMBRANDT® has updated its original DEEPLY WHITE® + Peroxide fluoride toothpaste to improve flavor and value.